Abstract: The present invention relates in general to the field of measuring technology, and more particularly to methods and systems for measuring the distance to remote objects, and can be used for determining the distance to a remote object when viewed from a viewing point situated at a given height.

Abstract: The invention relates to diagnostics, namely to a reagent kit, a rapid method and a device for detecting the fact of chronic, ischemia-linked brain pathology. A special feature of the invention is the use of an immunoactive hybrid peptide produced as a product of two fragments of the NMDA neuroreceptor subunits. A device is described that allows quick and convenient testing of autoantibodies in the patient's blood that recognize the hybrid peptide. The method of detection of autoantibodies is based on the principle of lateral flow immunochromatography. The invention can be used for prophylactic medical examination (screening of chronic ischemia-linked brain lesions), to detect decompensated chronic cerebral ischemia at the prehospital stage by general practitioners or neurologists, as well as in neurosurgery and sports medicine for diagnostics of delayed cerebral ischemia in persons with craniocerebral injury.

Abstract: A light fixture comprising a set of known LEDs which have different emission spectra in a range of the order of 400-800 nm and are equipped with drivers, is characterized in that from the known LEDs having different spectra, LEDs are selected which have emission spectra in a range of 443-650 nm, wherein the spectra of the selected LEDs overlap one another at different spectral sections of the range, preferably at a level of 0.5 of the maximum amplitude, wherein 5 types of LEDs each having a power of 10 W in the preferred embodiment are used, including warm white, dark blue, light blue, green and full spectrum, wherein the drivers of the LEDs are capable of feeding energy thereto that amounts to 1.4, 0.3, 0.3, and 1.25, respectively, of the level of energy supplied to the full-spectrum LED. The invention provides a light fixture with an emission spectrum corresponding to sunlight while minimizing the total number of LEDs used.

Abstract: The present method makes use of a second receiver-transmitter pair, which, together with a first pair, forms a quadrilateral figure, the horizontal sides of which are parallel to the level of a liquid. In addition, the values of the energy characteristics of Lamb waves propagated simultaneously both between each of the horizontal receiver-transmitter pairs and between a second vertical receiver-transmitter pair are calculated using values obtained from certain horizontal pairs to determine the initial and final values of the measuring scale of other pairs, by means of which the height of the liquid level is determined and/or measured.

Abstract: The invention relates to diagnostics, namely to a reagent kit, a rapid method and a device for detecting the fact of chronic, ischemia-linked brain pathology. A special feature of the invention is the use of an immunoactive hybrid peptide produced as a product of two fragments of the NMDA neuroreceptor subunits. A device is described that allows quick and convenient testing of autoantibodies in the patient's blood that recognize the hybrid peptide. The method of detection of autoantibodies is based on the principle of lateral flow immunochromatography. The invention can be used for prophylactic medical examination (screening of chronic ischemia-linked brain lesions), to detect decompensated chronic cerebral ischemia at the prehospital stage by general practitioners or neurologists, as well as in neurosurgery and sports medicine for diagnostics of delayed cerebral ischemia in persons with craniocerebral injury.

Abstract: This invention relates to a measurement equipment and can be used to create means of measuring coordinates and angular values of an object freely moving in space with six degrees of freedom. The invention can be applied in human-machine interfaces as a coordinate input device, particularly, in training systems, in robotics, in augmented, virtual reality and mixed reality systems. The technical result is to increase the measurement accuracy by eliminating the measurement error of the gravity vector direction caused by the movement of the platform with sensors.

Abstract: A single- or multilayer film is disclosed, the film made on the basis of a blend of (co)polyamide and polyvinyl alcohol, soluble in at least one solvent A, comprising more than 50% water, at that said film comprising polyvinyl alcohol—PVAs, soluble in the same solvent A, and bonded polyvinyl alcohol—PVAB, which (i) is virtually insoluble in the same solvent A at temperatures from 18° C. to the initial boiling point at normal pressure, (ii) is soluble in at least one of the solvents, capable of dissolving (co)polyamide, (iii) gives the typical for PVA color reaction with iodine, and (iv) reacts with at least one primary amine, with formation of water-soluble PVA, wherein the CB/CS ratio, where CB is the film content for PVAB, that becomes water-soluble after its treatment with said primary amine, and Cs is the content of PVAs in the film, is not less than 0.05.

Abstract: Invention lies in the field of measuring equipment for determination of frictional parameters of surfaces of aerodrome runways or road pavements. The method includes rolling motion of a measuring wheel by a vehicle on a monitored surface, determination of its motion speed, force of its normal load on a surface and its angular rotational velocity, application of braking moment to the axle of a wheel by means of electromagnetic induction brake, rotor of which is connected to the axle of the wheel, determination of a sliding coefficient of the wheel, change of braking moment to make current value the sliding coefficient closer to the assigned value, determination of force of traction between the wheel and the surface using an analog sensor of magnetic flux density mounted on the stator of electromagnetic brake between the poles of the latter, and determination of friction coefficient between the wheel and the surface.

Abstract: A nanoantibody specifically binding surface antigen of Chlamydia trachomatis and having SEQ ID NO:2 amino acid sequence is disclosed. A nanoantibody specifically binding surface antigen of Chlamydia trachomatis and having SEQ ID NO:4 amino acid sequence is disclosed. A nanoantibody with SEQ ID NO:2 amino acid sequence inhibits development of Chlamydia infection caused by C. trachomatis. A nanoantibody with SEQ ID NO:4 amino acid sequence inhibits development of Chlamydia infection caused by C. trachomatis. A method of in vitro inhibiting a Chlamydia infection caused by C. trachomatis has the steps of pretreating elementary bodies of C. trachomatis by a therapeutically efficient amount of a nanoantibody specifically binding to a surface antigen of Chlamydia trachomatis, the nanoantibody comprising an amino acid sequence SEQ ID NO: 4 or SEQ ID NO:4, and then adding the elementary bodies of C. trachomatis to target cells being infected.

Abstract: Methods and techniques to increase the reliability of detecting virus infections, particularly lymphotropism, to eliminate false negative reactions in testing blood for the presence of lymphotropic viruses during enzyme immunoassay (EIA) and polymerase chain reaction (PCR) testing, and to better detect viruses with lymphotropism in biological materials having a concentration of virus particles lower than the sensitivity threshold of existing EIA and PCR methods, thereby making the techniques of the present invention more reliable.

Abstract: The invention relates to the development of drugs intended for the prophylaxis and/or treatment of viral diseases caused, in particular, by herpes viruses. What are proposed are complex compounds of germanium having the general structural formula: Gex[AD][CA]y[AA]z??(I), where AD is a derivative of a nitrogenous base of the purine series that has antiviral activity and can be selected from guanine derivatives, such as acyclovir, valacyclovir, gancyclovir and pencyclovir, or from adenine derivatives, such as vidarabine; CA is a hydroxycarboxylic acid which can be selected from acids such as (but not limited to) citric acid, lactic acid and malic acid; AA is an amino acid which can be selected from various a-amino acids, such as arginine, glycine, lysine and threonine, and where x=1-2, y=2-4 and z=0-2. Complex compounds of germanium have a high level of antiviral and immune-stimulating activity and are readily soluble in water.

Abstract: Devices and methods for rescuing people from high-rise facilities, for example, upper floors of multi-storey buildings. A rescue device from a high-rise building includes several flexible spokes interconnected on one end to form a pyramidal figure, wherein the spokes are located on the edges, an aerodynamic deceleration element fastened to the spokes, connectors located between the adjacent flexible spokes, in so doing the connectors are located at some distance from the ends of the flexible spokes, a buffer element fastened in a point of connection of the flexible spokes and a means of fastening an object to be rescued fastened in the point of connection of the flexible spokes on the other side with respect to the buffer element, in so doing each of the flexible spokes is embodied as curved sideways from a central axis of the device.

Abstract: The invention relates to the use of glutaric acid derivatives of general formula (I), which are disclosed in the invention description, as anti-arrhythmic agents.

Abstract: An apparatus for the emergency lowering of a person from a high-rise building is fastened on the person's back. The apparatus includes an inflatable central toroidal chamber having a membrane for accommodating the person. The chamber is connected on one side to inflatable shafts which, upon inflation, are arranged in a cone, and which are interconnected by inflatable connectors. The chamber is connected on the other side to an inflatable damping structure with a toroidal inflatable chamber connected by inflatable shafts to the central toroidal chamber. The toroidal inflatable chamber of the damping structure has a diameter which is greater than the diameter of the central toroidal chamber and is less than the diameter of the base of the cone formed by shafts straightened out upon inflation. An air-impermeable perforated fabric is stretched between the shafts and toroidal chambers. An independent gas source is connected to one of the toroidal inflatable chambers or to one of the inflatable shafts.

Abstract: Disclosed is a method of improving the conditioned reflex habit, the muscle tonus, or the motion coordination of a patient after suffering trauma to the brain cortex that involves administering to the patient an effective amount of a composition containing peptide glutamyl-aspartyl-arginine of the formula H-Glu-Asp-Arg-OH as its active base.

Abstract: The invention relates to the field of thermal processing of articles consisting of steel and iron-based alloys with a carbon content of up to 4.3% by weight. In order to reduce the duration of the technological processes used for producing articles consisting of iron-based alloys with a set structural state, the first variant of the method comprises heating the articles so as to form austenite and then cooling, which is performed under conditions which ensure the formation, in the structure of the alloy, of regions of austenite with a chemical composition similar to eutectoid with the subsequent formation in said regions of marinite and a set structural state so as to produce perlite with a different degree of dispersion and/or hardened structures.

Abstract: Disclosed is a method of treating diseases. traumas. as well as consequences of traumas of the central nervous system. and a method for stimulating neurons regeneration. which involves the use of a peptide glutamyl-aspartyl-arginine. Also disclosed are a pharmaceutical composition containing the above peptide and a pharmaceutically acceptable carrier and a method of stimulating the regeneration of neurons by administering to a patient a pharmaceutical composition containing the above peptide in the dose of 0.01-100 ?g/kg of body weight at least once a day during a period necessary for attaining the therapeutic effect. such administration being performed parenterally.

Abstract: This invention relates to continuous standing-wave linear electron accelerator (9) comprising a low-energy electron source (10), for example, within a range of 10-20 keV, an accelerating structure (1 or 1?) for accelerating low initial energy electrons to required values; at least, one high-frequency power supply (11) for the said accelerating structure (1 or 1?); a power supply (13) for said electron source (10) and high-frequency power supply (11); a receiving antenna (14), which is arranged in accelerating unit of accelerating structure (1 or 1?) and is used for emitting of high-frequency signal for controlling the amplitude and phase of accelerating field. Low-energy electron beam is directed to the first unit of accelerating structure (1 or 1?) contained successively accelerating units (2, 3, 4i). The first of them is embodied in the form of a bunch resonator (2), the second unit is embodied in the form of a buster resonator (3), and successive units (4i) are used for increasing the electron energy.

Abstract: Low-injection energy electrons are accelerated in a continuous standing wave linear accelerator. Electron flow is supplied directly from a low-energy electron source to subsequent sequential accelerating units interconnected via connection cells. By grouping electrons in the first bunch resonator at a determined gap voltage, increasing the electron energy in a booster resonator and accelerating the electron energy in the accelerating unit, the optimal phase of particles with respect to the electromagnetic field is ensured. The length of each accelerating structure segment, which is located between centers of the adjacent cells, is based on the equality between the relation of the length of each following segment to the length of the previous segment and the relation of the average electron speed in the previous segment to the average electron speed in the following segment.

Abstract: An apparatus for the emergency lowering of a person from a high-rise building is fastened on the person's back. The apparatus includes an inflatable central toroidal chamber having a membrane for accommodating the person. The chamber is connected on one side to inflatable shafts which, upon inflation, are arranged in a cone, and which are interconnected by inflatable connectors. The chamber is connected on the other side to an inflatable damping structure with a toroidal inflatable chamber connected by inflatable shafts to the central toroidal chamber. The toroidal inflatable chamber of the damping structure has a diameter which is greater than the diameter of the central toroidal chamber and is less than the diameter of the base of the cone formed by shafts straightened out upon inflation. An air-impermeable perforated fabric is stretched between the shafts and toroidal chambers. An independent gas source is connected to one of the toroidal inflatable chambers or to one of the inflatable shafts.